LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Reset all filters
01 1LGM Pharma
02 1Jai Radhe Sales
03 1Allastir
04 1Amicogen China Biopharm Co. - Ltd
05 1Anthem Biosciences
06 1Aspire Lifesciences Pvt Ltd
07 1Chemvisai Labs
08 1Dalian Richon Chem
09 1DongWoo Syntech
10 1Hamari chemicals
11 1Hangzhou Think Chemical Co.Ltd
12 1Jeil Pharmaceutical Co., Ltd
13 3KOLON Life Science, Inc
14 1Nippon Kayaku
15 1Nishchem International Pvt. Ltd
16 1Pharmaxyn laboratories Ltd
17 1Sun Pharmaceutical Industries Limited
18 1Suzhou Ryway Biotech
19 1Synergene Active Ingredients Pvt Ltd
20 2Tianwei Biotech Group
21 1Venkata Narayana Active Ingredients
22 1Wuxi Further Pharmaceutical Co Ltd
23 1Yonezawa Hamari Chemicals\
24 1Yuhan Corporation
25 2Zhejiang Hisoar Pharmaceutical
Reset all filters
Reset all filters
Reset all filters
Reset all filters
53
PharmaCompass offers a list of Voglibose API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Voglibose manufacturer or Voglibose supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Voglibose manufacturer or Voglibose supplier.
PharmaCompass also assists you with knowing the Voglibose API Price utilized in the formulation of products. Voglibose API Price is not always fixed or binding as the Voglibose Price is obtained through a variety of data sources. The Voglibose Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 3,4-Dideoxy-4-{[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-2-D-epi-inositol; N-(1,3-Dihydroxyprop-2-yl)valiolamine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 3,4-Dideoxy-4-{[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-2-D-epi-inositol; N-(1,3-Dihydroxyprop-2-yl)valiolamine, including repackagers and relabelers. The FDA regulates 3,4-Dideoxy-4-{[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-2-D-epi-inositol; N-(1,3-Dihydroxyprop-2-yl)valiolamine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 3,4-Dideoxy-4-{[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-2-D-epi-inositol; N-(1,3-Dihydroxyprop-2-yl)valiolamine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 3,4-Dideoxy-4-{[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-2-D-epi-inositol; N-(1,3-Dihydroxyprop-2-yl)valiolamine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 3,4-Dideoxy-4-{[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-2-D-epi-inositol; N-(1,3-Dihydroxyprop-2-yl)valiolamine supplier is an individual or a company that provides 3,4-Dideoxy-4-{[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-2-D-epi-inositol; N-(1,3-Dihydroxyprop-2-yl)valiolamine active pharmaceutical ingredient (API) or 3,4-Dideoxy-4-{[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-2-D-epi-inositol; N-(1,3-Dihydroxyprop-2-yl)valiolamine finished formulations upon request. The 3,4-Dideoxy-4-{[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-2-D-epi-inositol; N-(1,3-Dihydroxyprop-2-yl)valiolamine suppliers may include 3,4-Dideoxy-4-{[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-2-D-epi-inositol; N-(1,3-Dihydroxyprop-2-yl)valiolamine API manufacturers, exporters, distributors and traders.
click here to find a list of 3,4-Dideoxy-4-{[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-2-D-epi-inositol; N-(1,3-Dihydroxyprop-2-yl)valiolamine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
We have 25 companies offering 3,4-Dideoxy-4-{[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-2-D-epi-inositol; N-(1,3-Dihydroxyprop-2-yl)valiolamine
Get in contact with the supplier of your choice: